Economic analyses are critical to understanding the relationship between resource use, treatment planning, and outcomes of substance abuse treatment. Developing methods to obtain precise cost estimates while balancing limited research funds is one important component for conducting these analyses. As a new investigator to the field completing a """"""""three-paper"""""""" dissertation requirement of the PhD in Social Policy at Brandeis University, I am proposing to conduct and expand one of the proposed dissertation studies under this grant application. While the full dissertation involves components pertaining to cost measurement, cost function modeling, and cost-effectiveness analysis, this proposal focuses on the issue of cost measurement. More specifically, this project will involve both a broad conceptual analysis of different costing methodologies as well as an empirical reliability study of a brief, telephone-based, cost analysis instrument (Cost Data Audit Instrument, CDAI) used in the Alcohol and Drug Services Study (ADSS). The CDAI uses an Excel workbook to simultaneously obtain data, report consistency and unit costs, and provide feedback. The conceptual analysis will contain a thorough review of the objectives, administration, and content of various costing methodologies in the field. The empirical analysis will involve collecting substance abuse treatment cost data from 50 substance abuse treatment programs to compare the results of the CDAI to the results of the Drug Abuse Treatment Cost Analysis Program (DATCAP). Differences will be examined in all major component features of the CDAI and the DATCAP on both detail and composite measures of client volume, counseling activities, personnel costs, and non-personnel costs. All facilities will be involved in participating in a program -specific """"""""reconciliation process"""""""" to identify from a program perspective, strengths and problems areas in the two instruments, and to resolve differences in the results. Finally, this study will recommend ways for refining cost analyses for the next generation of costing studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Research Grants (R03)
Project #
7R03DA018702-02
Application #
7055445
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Duffy, Sarah Q
Project Start
2004-09-30
Project End
2006-08-31
Budget Start
2005-02-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$57,426
Indirect Cost
Name
Family Health International
Department
Type
DUNS #
067180786
City
Research Triangle Park
State
NC
Country
United States
Zip Code
27713
Beaston-Blaakman, A; Shepard, D S; Stone, N et al. (2007) Cost-effectiveness of clinical interventions for AIDS wasting. AIDS Care 19:996-1001